This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n7http://linked.opendata.cz/resource/mesh/concept/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n8http://linked.opendata.cz/resource/fda-spl/ingredient/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
ncihttp://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
n5http://linked.opendata.cz/resource/ndfrt/ingredient/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
nci:C1417
rdf:type
owl:Class
rdfs:label
Goserelin Acetate
rdfs:subClassOf
nci:C2022 _:vb677324 _:vb677325 _:vb677326 _:vb677322 _:vb677323
nci:A6
nci:C1374
nci:A8
nci:C63923
nci:P106
Pharmacologic Substance Amino Acid, Peptide, or Protein
nci:P108
Goserelin Acetate
nci:P175
606864
nci:P207
C0700476
nci:P210
65807-02-5
nci:P302
Breast Carcinoma; Prostate Carcinoma; Endometriosis
nci:P319
6YUU2PV0U8
nci:P322
FDA
nci:P329
40224
nci:P330
40224
nci:P350
C59H84N18O14.C2H4O2
nci:P366
Goserelin_Acetate
nci:P90
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Zoladex</n0:term-name><n0:term-group>BR</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>D-Ser(bu(t))(6)azgly(10)-LHRH Acetate</n0:term-name><n0:term-group>SN</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>GOSERELIN ACETATE</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>FDA</n0:term-source><n0:source-code>6YUU2PV0U8</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Zoladex</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>DTP</n0:term-source><n0:source-code>NSC0606864</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>ZDX</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Goserelin Acetate</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04)</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code
C1417
owl:sameAs
n5:N0000179609 n8:6YUU2PV0U8
n6:hasConcept
n7:M0373293
Subject Item
_:vb677322
rdf:type
owl:Restriction
owl:onProperty
nci:R125
owl:someValuesFrom
nci:C41524
Subject Item
_:vb677323
rdf:type
owl:Restriction
owl:onProperty
nci:R146
owl:someValuesFrom
nci:C38910
Subject Item
_:vb677324
rdf:type
owl:Restriction
owl:onProperty
nci:R125
owl:someValuesFrom
nci:C41476
Subject Item
_:vb677325
rdf:type
owl:Restriction
owl:onProperty
nci:R124
owl:someValuesFrom
nci:C40702
Subject Item
_:vb677326
rdf:type
owl:Restriction
owl:onProperty
nci:R125
owl:someValuesFrom
nci:C41494